| Secondary |
| Product Used For Unknown Indication |
45.2% |
| Drug Abuse |
31.4% |
| Neuralgia |
11.6% |
| Drug Use For Unknown Indication |
3.3% |
| Complex Regional Pain Syndrome |
1.7% |
| Ovarian Epithelial Cancer |
1.2% |
| Contraception |
1.1% |
| Major Depression |
1.1% |
| Mental Disorder |
0.8% |
| Depression |
0.4% |
| Hypertension |
0.4% |
| Pain |
0.4% |
| Prostate Cancer Metastatic |
0.3% |
| Suicide Attempt |
0.3% |
| Anxiety Disorder |
0.1% |
| Arthropathy |
0.1% |
| Crohn's Disease |
0.1% |
| Dyspepsia |
0.1% |
| Metastases To Bone |
0.1% |
| Osteoarthritis |
0.1% |
|
| Withdrawal Syndrome |
26.4% |
| Toxicity To Various Agents |
13.2% |
| Vomiting |
7.5% |
| Hallucination, Visual |
5.7% |
| Pulmonary Artery Stenosis |
5.7% |
| Foot Fracture |
3.8% |
| Gait Disturbance |
3.8% |
| Pneumonia |
3.8% |
| Surgery |
3.8% |
| Syncope |
3.8% |
| Transaminases Increased |
3.8% |
| Weight Increased |
3.8% |
| Congenital Choroid Plexus Cyst |
1.9% |
| Convulsion Neonatal |
1.9% |
| Cyst |
1.9% |
| Gestational Diabetes |
1.9% |
| Haemorrhagic Diathesis |
1.9% |
| Memory Impairment |
1.9% |
| Myoclonus |
1.9% |
| Neurotoxicity |
1.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
24.2% |
| Rheumatoid Arthritis |
22.2% |
| Drug Use For Unknown Indication |
19.0% |
| Hypertension |
6.7% |
| Pain |
5.0% |
| Renal Transplant |
2.8% |
| Prophylaxis |
2.3% |
| Osteoporosis |
2.0% |
| Arthritis |
1.7% |
| Neuralgia |
1.6% |
| Asthma |
1.4% |
| Breast Cancer |
1.4% |
| Restless Legs Syndrome |
1.4% |
| Depression |
1.3% |
| Malignant Melanoma |
1.3% |
| Multiple Myeloma |
1.3% |
| Bone Pain |
1.1% |
| Hypersensitivity |
1.1% |
| Non-small Cell Lung Cancer |
1.1% |
| Sepsis |
1.1% |
|
| Toxicity To Various Agents |
9.4% |
| Gastrointestinal Ulcer Haemorrhage |
6.3% |
| Myocardial Infarction |
6.3% |
| Pain |
6.3% |
| Pain In Extremity |
6.3% |
| Renal Failure |
6.3% |
| Septic Shock |
6.3% |
| Urinary Tract Infection |
6.3% |
| Abdominal Pain |
4.7% |
| Neuropathy Peripheral |
4.7% |
| Pancreatitis Necrotising |
4.7% |
| Restlessness |
4.7% |
| Visual Acuity Reduced |
4.7% |
| Withdrawal Syndrome |
4.7% |
| Abscess |
3.1% |
| Alveolitis |
3.1% |
| Anal Fissure |
3.1% |
| Ascites |
3.1% |
| Depression |
3.1% |
| Diarrhoea |
3.1% |
|
| Interacting |
| Product Used For Unknown Indication |
46.7% |
| Depression |
13.3% |
| Mental Disorder |
13.3% |
| Anticoagulant Therapy |
6.7% |
| Herpes Zoster |
6.7% |
| Neuralgia |
6.7% |
| Trigeminal Neuralgia |
6.7% |
|
| Liver Disorder |
28.6% |
| Toxicity To Various Agents |
28.6% |
| International Normalised Ratio Increased |
14.3% |
| Pain |
14.3% |
| Rhabdomyolysis |
14.3% |
|
